|Bid||0.0700 x 1374700|
|Ask||0.0770 x 6297500|
|Day's range||0.0650 - 0.0700|
|52-week range||0.0640 - 0.1575|
|Beta (5Y monthly)||0.57|
|PE ratio (TTM)||N/A|
|Earnings date||24 Aug 2022 - 29 Aug 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||0.20|
Australian medical technology company LBT Innovations Limited (ASX: LBT) (LBT or the Company), a leader in medical technology automation using artificial intelligence, is pleased to announce the signing of an exclusive Distribution Agreement for the APAS® Independence in the United States (the Agreement) with Remel Inc., a part of Thermo Fisher Scientific, Inc. (Thermo Fisher).
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...